Skip to content
Advertisement

In this Friday, March 19, 2021, file photo Medical staff members administer the AstraZeneca vaccine at La Nuvola (The Cloud) convention center that was temporarily turned into a COVID-19 vaccination hub, in Rome. AstraZeneca said Monday, March 22, 2021, that advanced trial data from a U.S. study on its COVID vaccine shows it is 79% effective. The U.S. study comprised 30,000 volunteers, 20,000 of whom were given the vaccine while the rest got dummy shots. (AP Photo/Gregorio Borgia)
Photo by: Gregorio Borgia
In this Friday, March 19, 2021, file photo Medical staff members administer the AstraZeneca vaccine at La Nuvola (The Cloud) convention center that was temporarily turned into a COVID-19 vaccination hub, in Rome. AstraZeneca said Monday, March 22, 2021, that advanced trial data from a U.S. study on its COVID vaccine shows it is 79% effective. The U.S. study comprised 30,000 volunteers, 20,000 of whom were given the vaccine while the rest got dummy shots. (AP Photo/Gregorio Borgia)

Featured Photo Galleries